Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|---|
Total reported revenue | 1.2B | 1.0B | 2.3B | 2.0B |
Cost of revenue | 899.6M | 823.7M | 2.1B | 1.8B |
Gross profit | 254.5M | 224.8M | 195.0M | 205.4M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 171.3M | 141.4M | 151.1M | 136.8M |
Other operating expenses | — | — | — | — |
Operating income | 83.1M | 83.5M | 43.9M | 68.6M |
Non operating interest income | ||||
Income | 4.1M | 3.7M | 4.2M | 4.6M |
Expense | 14.4M | 10.1M | 18.5M | 8.9M |
Other income expense | — | — | — | — |
Pretax income | 143.1M | 98.8M | 3.4M | 50.1M |
Tax provision | -17.4M | 42.3M | -357.0M | 48.8M |
Net income | 160.5M | 56.5M | 360.4M | 1.3M |
Basic EPS | — | 10.0 | — | -5.4 |
Diluted EPS | — | 10.0 | — | -5.4 |
Basic average shares | — | 5.4M | — | 5.4M |
Diluted average shares | — | 5.4M | — | 5.4M |
EBITDA | 101.4M | 119.8M | -21.9M | 26.9M |
Net income from continuing op. | 143.1M | 98.8M | 3.4M | 50.1M |
Minority interests | -30.8M | -2.3M | -5.1M | -30.5M |
Preferred stock dividends | 0 | 0 | 0 | 0 |